Barclays PLC Viatris Inc Transaction History
Barclays PLC
- $353 Billion
- Q1 2025
A detailed history of Barclays PLC transactions in Viatris Inc stock. As of the latest transaction made, Barclays PLC holds 3,367,709 shares of VTRS stock, worth $30.4 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,367,709
Previous 2,969,479
13.41%
Holding current value
$30.4 Million
Previous $37 Million
20.66%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding VTRS
# of Institutions
1,136Shares Held
953MCall Options Held
4.15MPut Options Held
2.65M-
Vanguard Group Inc Valley Forge, PA145MShares$1.31 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY92.7MShares$838 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD74.5MShares$673 Million0.08% of portfolio
-
Chris Davis Davis Selected Advisers | Tucson, Az64.9MShares$587 Million3.35% of portfolio
-
State Street Corp Boston, MA61.5MShares$556 Million0.02% of portfolio
About Viatris Inc
- Ticker VTRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,212,669,952
- Market Cap $11B
- Description
- Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...